TY - JOUR
T1 - Human retinal pigment epithelial cells possess v1 vasopressin receptors
AU - Friedman, Zvi
AU - Delahunty, T. Mary
AU - Linden, Joel
AU - Campochiaro, Peter A.
N1 - Funding Information:
ACKNOWLEDGEMENTS Supported by PHS grant EY05951 (PAC) and an unrestricted grant from Research to Prevent Blindness, Inc., New York, N.Y. S.L. is an established investigator of the American Heart Association. The authors would like to express their appreciation to Stephanie Allen for her assistance in preparation of the manuscript and to Richard B. Crook, Ph.D. for his assistance in obtaining the Vasopressin antagonist, SKF 101926
PY - 1991
Y1 - 1991
N2 - Membrane preparations of cultured human retinal pigment epithelial (RPE) cells were incubated with various concentrations of [3H]arginine vasopressin (AVP) in the presence and absence of 10 uM nonradioactive AVP. Saturable, specific binding to a single site with a Kd of 6.2 nM and Bmax of 111 fmol/mg protein was detected. Vaaopressin had no effect on RPE cyclic AMP levels measured by radioimmunoassay. Intracellular calcium fluxes were measured by spectrofluorometry of RPE cell suspensions preloaded with quin 2. The baseline cytosolic calcium level was 217 ± 20 nM, and AVP caused a concentration-dependent increase in this level with a 3.5-fold maximal response at 10--6 M and an EC50 of 120 nM. The production of inositol phosphates was measured in RPE preloaded with [3H]myoinositol, and AVP caused a concentration-dependent increase in their production with a 2.1-fold maximal response at 10--5 M and an EC50 of 80 nM. A specific vasopressin receptor antagonist, SKF 101926, prevented the AVP-induced increase in calcium mobilization and ionistol phosphate production in RPE. These data suggest that RPE cells possess V1 AVP receptors coupled to calcium mobilization and inositol phosphate metabolism.
AB - Membrane preparations of cultured human retinal pigment epithelial (RPE) cells were incubated with various concentrations of [3H]arginine vasopressin (AVP) in the presence and absence of 10 uM nonradioactive AVP. Saturable, specific binding to a single site with a Kd of 6.2 nM and Bmax of 111 fmol/mg protein was detected. Vaaopressin had no effect on RPE cyclic AMP levels measured by radioimmunoassay. Intracellular calcium fluxes were measured by spectrofluorometry of RPE cell suspensions preloaded with quin 2. The baseline cytosolic calcium level was 217 ± 20 nM, and AVP caused a concentration-dependent increase in this level with a 3.5-fold maximal response at 10--6 M and an EC50 of 120 nM. The production of inositol phosphates was measured in RPE preloaded with [3H]myoinositol, and AVP caused a concentration-dependent increase in their production with a 2.1-fold maximal response at 10--5 M and an EC50 of 80 nM. A specific vasopressin receptor antagonist, SKF 101926, prevented the AVP-induced increase in calcium mobilization and ionistol phosphate production in RPE. These data suggest that RPE cells possess V1 AVP receptors coupled to calcium mobilization and inositol phosphate metabolism.
UR - http://www.scopus.com/inward/record.url?scp=0025737485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025737485&partnerID=8YFLogxK
U2 - 10.3109/02713689109013876
DO - 10.3109/02713689109013876
M3 - Article
C2 - 1665120
AN - SCOPUS:0025737485
SN - 0271-3683
VL - 10
SP - 811
EP - 816
JO - Current Eye Research
JF - Current Eye Research
IS - 9
ER -